1 Min Read
March 14 (Reuters) - Chiome Bioscience Inc :
* Says it received patent in the U.S. for its product ANTI-HUMAN TROP-2 ANTIBODY HAVING ANTI-TUMOR ACTIVITY IN VIVO
Source text in Japanese:goo.gl/Isq1Rs
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.